The U.S. Food and Drug Administration has confirmed that Boston Scientific Corporation did recall some of their cardiac defibrillators earlier in the month. Boston Scientific recalled approximately 73,000 implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators because of a flaw in the devices that can lead to the batteries dying sooner than expected. Boston Scientific says that most patients are not affected by the recall, but should be in touch with their physicians about possible action.

FDA Confirms Boston Scientific Defibrillator Recall